Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC
IntroductionTo assess the efficacy of progression-directed radiation therapy (PDRT) in patients with oligoprogressive non-small cell lung cancer (NSCLC), with particular focus on disease progression and changes in systemic therapy.Materials and methodsFrom January 2020 to October 2025, a retrospecti...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2026-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1766544/full |
| Tags: |
No Tags, Be the first to tag this record!
|
